期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

高尿酸血症与冠状动脉粥样硬化心脏病关系的探讨 被引量：8

原文传递
导出
摘要 目的探讨血尿酸水平与冠状动脉粥样硬化心脏病(冠心病)的关系及临床意义。方法检测经冠状动脉造影确诊的冠心病患者70例与40例非冠心病患者血尿酸水平,并将冠心病按稳定型心绞痛(A组),不稳定型心绞痛(B组),急性心肌梗死(C组)分为三组,并进行相关的统计分析。结果与对照组比较,冠心病组患者血尿酸水平明显高于对照组(P＜0．05),冠心病亚组B组与A组,C组与A组比较差异有统计学意义(P＜0．05),而B组与C组比较差异无统计学意义。结论高尿酸血症是冠心病发病的一个相关因素。
作者 王莉 汪一波
机构地区 临安市人民医院心内科
出处 《中国基层医药》 CAS 2006年第8期1346-1347,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 尿酸 冠心病
分类号 R541.4 [医药卫生—心血管疾病] R589 [医药卫生—内分泌]
  • 相关文献

参考文献9

  • 1FangJ.血尿酸与心血管病死亡率:1971-1992年WHANES流行病学随访研究.国外医学：心血管疾病分册,2000,27(6):363-363.
  • 2Ward HJ. Vric acid as an independent risk factor in the treatment of hypertension. Lancet, 1998,352:670.
  • 3Wannamethee SG. Is serum uric acid a risk factor for coronary heart disease. Journal of Human Hypertension, 1999,13 : 153-156.
  • 4Wieto FJ ,Zribarren C,Gross MD,et al. Uric acid and serum antioxidam capacity :a reaction to a the roscle rosis. 2000,148 : 131-139.
  • 5Conen D, Wietlisbach V, Bovet P, et al. Prevalence of hyperuricem ia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health, 2004.4 : 9.
  • 6Costa A, Iguala I, Bedini J, et al. Uric acid concentration in subjects at risk of type 2 diabetes mellitus:relationship to components of the metabolic syndrome. Metabolism, 2002,51:372-375.
  • 7Fessel WT. High uric as an indicator of cardlor ascular disease,independence from obesity. Am J Med, 1980,68 : 401-404.
  • 8王文标,沈卫峰,张建盛,张瑞岩.高尿酸血症与冠心病的相关性[J].中国动脉硬化杂志,2002,10(1):56-58. 被引量：100
  • 9苏工,米树华,陶红,王南晔,郑虹.代谢综合征患者血尿酸水平与冠心病的关系[J].中华内分泌代谢杂志,2005,21(1):66-67. 被引量：23

二级参考文献12

  • 1冯波,李栩,黄亦文,乐秀康,富明,陈明慧,戴明德,倪亚芳,赵竹芳,周凤英,孟仲莹,王惠玲,姚国良,张容,刘昊,张小倩.上海市浦东新区社区人群代谢综合征状况和相关危险因素分析[J].中华内分泌代谢杂志,2004,20(3):231-232. 被引量：34
  • 2Gorter PM, Olijhoek JK, van der Graaf Y, et al. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis, 2004,173:363-369.
  • 3Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA, 2000,283:2404-2410.
  • 4Nieto FJ, Iribarren C, Gross MD, et al. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis, 2000,148:131-139.
  • 5Conen D, Wietlisbach V, Bovet P, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health, 2004,4:9.
  • 6Costa A, Iguala I, Bedini J, et al. Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic syndrome. Metabolism, 2002,51:372-375.
  • 7Ross R. The pathogenesis of atherosclerosis. In:Eugene Braunwald, ed. Heart disease:A textbook of cardivascular medicine.5th ed. Philadelphia:Saunders, 1999; 1 105-126
  • 8Culleton BF, Larson MG, Kannel WB, et al. Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study . Ann Intern Med, 1999, 131: 7-13
  • 9Brand FN, Mc Gee DL, Kannel WB, et al. Original Coutrib utions of hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol, 1985, 121: 11-17
  • 10Freedman DS, Williamson DF, Genter EW, et al. Relation of serum acid to mortality and ischemic heart disease: The NHANESI Epidemiologic Follow-up study. Am J Epidemiol, 1995, 141: 637-644

共引文献122

同被引文献78

引证文献8

二级引证文献46

中国基层医药
2006年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部